Winners ECNP Poster Awards 2024

P.1423
Psilocybin vs escitalopram for depression: 6-month follow-up
Tommaso Barba, United Kingdom  

P.1232 Safety and efficacy of a cross-correction-based gene therapy approach for CDKL5 deficiency disorder
Giulia Candini, Italy

P.1040 Prediction of attention-deficit/hyperactivity disorder methylphenidate treatment response using volume-based and Radiomics-based T1 and ᠎᠎᠎diffusion tensor imaging features
Mingshi Chen, The Netherlands

P.2212 Cerebrospinal fluid synaptic biomarkers in a large cross-disorder cohort of psychiatric disorders
Andreas Göteson, Sweden

P.1087 From bungee jumps to depression slumps: an investigation into the interplay between stress and autophagy
Yara Mecdad, Germany

P.2137 AI-Based prediction of depression symptomatology in first episode psychosis patients: insights from the EUFEST and RAISE clinical trial
Sergio Mena Ortega, United Kingdom

P.3239 Cortical thickness alterations and systemic inflammation define long-Covid patients with cognitive impairment
Tonia Rocktäschel, Germany

P.3515 Disrupting microbiota composition and microbiota-gut-brain signalling: impacts on reward, motivation, and decision-making.
Brendan Sharvin, Ireland

P.2297 Sleep-related polygenic scores and multi-polygenic score approach to lithium response prediction in bipolar disorder
Marina Zafrilla López, Spain